Trademarkia Logo

Canada

C$
OCEGAIV
APPROVED

on 27 May 2025

Last Applicant/ Owned by

Boehringer Ingelheim International GmbH

55218 Ingelheim

DE

Serial Number

2255832 filed on 22nd Mar 2023

Correspondent Address

MARKS & CLERK

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

OCEGAIV

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system; pharmaceutical preparations for the treatment of genitourinary system diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; Pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, namely, autoimmune diseases and disorders, and treatment of infectious diseases namely viral infections.


Classification kind code

12

Mark Details


Serial Number

2255832

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 21st Jan 2025
Agent Changed
Submitted for opposition 22
on 6th Aug 2024
Search Recorded
Submitted for opposition 20
on 6th Aug 2024
Examiner's First Report
Submitted for opposition 223
on 6th Aug 2024
Total Provisional Refusal
Submitted for opposition 256
on 4th Mar 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 4th May 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 3rd May 2023
Created
Submitted for opposition 31
on 3rd May 2023
Formalized
Submitted for opposition 30
on 22nd Mar 2023
Filed
Submitted for opposition 228
on 22nd Mar 2023
International Registration